【5】持続皮下インスリン注入療法 （CSII : continuous …

The use of variable rate intravenous insulin infusion ...

3 This guideline is for the use of a variable rate intravenous insulin infusion (VRIII) in adult inpatients with medical conditions and diabetes/hyperglycaemia, who require intravenous administration of insulin to keep their blood

  Rates, Variable, Intravenous, Insulin, Infusion, Variable rate intravenous insulin infusion, Vriii

107 Continuous or Intermittent Monitoring of Glucose

2 best practice for patients not on an insulin pump prior to the pregnancy. Prior use of an intermittent (72-hour) glucose monitor would be considered a part of best practices for those considering use of a

  Monitoring, Continuous, Intermittent, Insulin, Continuous or intermittent monitoring of

Intensive Intraoperative Insulin Therapy versus ...

the infusions to maintain blood glucose levels between 4.4 (80 mg/dL) and 5.6 mmol/L (100 mg/dL). We adjusted the dose according to a standardized algorithm used by

  Versus, Therapy, Intensive, Insulin, Intraoperative, Intensive intraoperative insulin therapy versus

Procedure for Subcutaneous Insertion, Removal, and ...

The subcutaneous site must be changed every seven (7) days or sooner, if necessary. When changing sites, the chosen sites should be rotated to avoid using the same site repeatedly.

  Procedures, Removal, Insertion, Procedure for subcutaneous insertion, Subcutaneous

8. Pharmacologic Approaches to Glycemic Treatment ...

Educationregardingmatchingprandial insulin dosing to carbohydrate intake, premeal glucose levels, and anticipated activity should be considered, and se-

  Insulin

Insulin allergy: clinical manifestations and management ...

Review article Insulin allergy: clinical manifestations and management strategies Adverse reactions to insulin have significantly decreased since the introduction of human insulin preparations (1).

  Management, Clinical, Allergy, Insulin, Manifestations, Insulin allergy, Clinical manifestations and management

G ARTICLE IN PRESS - University at Buffalo

Please citethisarticleinpressas:K.Lunze,etal.,Bloodglucosecontrolalgorithmsfortype1diabeticpatients:Amethodologicalreview,Biomed. Signal G ARTICLE IN PRESS control